Category Archives: Diabetes

NPC Archive Item: Cases of lung cancer reported in clinical trials of inhaled insulin (Exubera®▼)

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. http://www.fda.gov/medwatch/safety/2008/safety08.htm#exubera The FDA in America has issued a Dear Healthcare Professional letter regarding cases of lung cancer in clinical trials and during post-marketing surveillance in patients treated with Pfizer’s […]

NPC Archive Item: Improving emergency and inpatient care for people with diabetes

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. What is the background to this? Released by the National Diabetes Support Team in April 2008, ‘Improving emergency and inpatient care for people with diabetes’ is the report of […]

NPC Archive Item: Self-monitoring in type 2 diabetes not treated with insulin usually doesn’t help, can worsen quality of life, and may waste NHS resources

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. Two new studies suggest that newly diagnosed people with type 2 diabetes are unlikely to gain any benefits from monitoring their blood glucose themselves. Self-monitoring of blood glucose (SMBG) […]

NPC Archive Item: More on the safety of rosiglitazone

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. Monday, November 19th, 2007 Corrected Monday, March 31st 2008 FDA adds Boxed Warning for heart-related risks to anti-diabetes drug Avandia. FDA News. November 14th 2007. Accessed from http://www.fda.gov/bbs/topics/NEWS/2007/NEW01743.html on […]

NPC Archive Item: Vildagliptin launched in UK

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. Vildagliptin▼(Galvus ®), a dipeptidyl peptidase type 4 (DPP-4) inhibitor and vildagliptin/metformin▼ (Eucreas®) have recently been launched in the UK. Vildagliptin is licensed for the treatment of type 2 diabetes […]

NPC Archive Item: Intensive interventions in type 2 diabetes reduce mortality

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. Gaede P, Lund-Andersen H, Parving H-H, et al. Effect of a multifactorial intervention on mortality in type 2 diabetes. NEJM 2008:358:580–91 What is the background to this? People with […]

NPC Archive Item: Statins for all patients with diabetes?

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. Cholesterol Treatment Trialist’s Collaborators. Efficacy of cholesterol-lowering in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008;371: 117–25 What is the background to this? […]

NPC Archive Item: Cardiovascular safety of glitazones in older people

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. Lipscombe L, Gomes T, Lévesque LE, et al. Thiazolidinediones and cardiovascular outcomes in older patients with diabetes. JAMA. 2007;298:2634-43. A large population-based study from Canada increases concerns over the […]